CLINICAL_TRIALS
trial_result
· 2017-03-10
Clinical Trial Update: Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) [Phase 3]
Summary
Phase 3 clinical trial P02095 evaluating posaconazole for invasive fungal infections has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Mycoses | Phase 3 | Status: COMPLETED